Medical Breakthroughs Reliant on Better Clinical Trials
Harsha Rajasimha
November 7, 2023
The cost of patients dropping out of clinical trials continues to be a major problem for the development of new drugs and treatments around the
The cost of patients dropping out of clinical trials continues to be a major problem for the development of new drugs and treatments around the
Dr. Harsha Rajasimha, Founder and CEO of Jeeva Informatics, highlights the importance and value of Investigator-Initiated Trials (IITs) in gathering real-world data on the efficacy,
The Inflation Reduction Act of 2022 (IRA) covers new and reinstated tax laws that will affect individuals and businesses. Through IRA, President Joe Biden delivered
Drug pricing controls imposed by the Inflation Reduction Act of 2022 may appear positive for patients in the short term. However, these controls may have
CCF grants support startups, critical early technology testing and market validation efforts. RICHMOND, VIRGINIA, UNITED STATES, June 27, 2023/EINPresswire.com/ — The Virginia Innovation Partnership Corporation
The FDA has released new guidance for decentralized clinical trials (DCTs) for drugs, biological products, and medical devices to improve DCT implementation. Dr. Harsha Rajasimha,
Genomics expert and social entrepreneur, Harsha Rajasimha, looks to bridge OMICS and Exposure Health with partner DailyBreath at the inaugural total exposure health conference this
The value of life-saving drugs for patients suffering from serious diseases is priceless. But the current economic environment is stifling the biopharmaceutical pipeline of up-and-coming
Clinical trials are the long and complex process by which biopharmaceutical companies must prove the safety and efficacy of investigational new therapies to FDA before
Between logistical burdens, distrust in the healthcare system, and lack of awareness and information in many non-English languages, key demographic groups like women, children, low-income
Jeeva Informatics Solutions Inc.